Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

253.89 -4.62 (-1.79%)
Streaming Delayed Price Updated: 10:44 AM EDT, Jun 30, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
Johnson & Johnson Posts Solid Q1 To Kickstart 'Year Of Accelerating Growth,' Says Bullish Analyst ↗
Johnson & Johnson reports strong Q1, beating expectations and setting the stage for future growth. Analysts maintain Buy rating. 
Via Benzinga
News headline image
Consolidation Fever: Boston Scientific’s $14.9 Billion Bet on Penumbra Signals New Era in MedTech M&A
In a move that has sent shockwaves through the healthcare sector, Boston Scientific Corporation (NYSE: BSX) announced its definitive agreement to acquire Penumbra, Inc. (NYSE: PEN) for approximately... 
Via MarketMinute
Topics Economy
News headline image
Transcript: Johnson & Johnson Q1 2026 Earnings Conference Call ↗
 
Via Benzinga
News headline image
Oil Drops, Dimon Warns, and the Record Is Within Reach ↗
Within 0.2% of its January all-time high. That's where the S&P 500 closed on Tuesday, not quite there yet, but close enough that the question investors are asking has quietly shifted from "when does... 
Via Chartmill
Topics Artificial Intelligence Economy Government
News headline image
MedTech Surge and Oncology Resilience Drive Johnson & Johnson to Q1 Earnings Beat
In a resounding display of corporate resilience, Johnson & Johnson (NYSE:JNJ) reported first-quarter 2026 financial results that surpassed Wall Street expectations, signaling a successful navigation of... 
Via MarketMinute
Topics Bankruptcy Earnings Economy
News headline image
What Makes a Healthcare Stock Worth Holding Through a Recession? ↗
Not all healthcare stocks are defensive in a downturn. Here's what to consider. 
Via The Motley Fool
Topics Economy
News headline image
Johnson & Johnson: A 20% Gain Looks Easy After Q1 Earnings Results ↗
Via MarketBeat
News headline image
Johnson & Johnson Q1 2026 Earnings Call Transcript ↗
Johnson & Johnson (NASDAQ: JNJ) reported first-quarter financial results on Tuesday. The transcript from the company's first-quarter earnings call has been provided below. 
Via Benzinga
Topics Earnings
News headline image
Johnson & Johnson Shatters Expectations in Q1 2026, Raising Full-Year Outlook as Healthcare Giant Pushes Toward $100 Billion Milestone
NEW BRUNSWICK, N.J. — In a powerful display of resilience and strategic execution, Johnson & Johnson (NYSE: JNJ) reported first-quarter 2026 financial results that exceeded Wall Street estimates across... 
Via MarketMinute
Topics Economy Intellectual Property
News headline image
Johnson & Johnson Q1 Performance: Cancer Drug Revenue Grows, Free Cash Flow Falls, Hikes Dividend ↗
Johnson & Johnson Q1 pharma growth offsets immunology decline; company raises guidance and extends dividend streak. 
Via Benzinga
News headline image
The New J&J: A 2026 Deep Dive into the Global Healthcare Titan
As of April 14, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different entity than it was only three years ago. Following the successful spin-off of its consumer health division, Kenvue,... 
Via Finterra
Topics Artificial Intelligence Death Economy
News headline image
Dow Jones' J&J Slips Despite Beating First-Quarter Calls, Hiking Guidance ↗
Johnson & Johnson stock fell early Tuesday despite better-than-expected first-quarter sales and earnings, and a guidance hike. 
Via Investor's Business Daily
Topics Stocks
News headline image
Johnson & Johnson Announces 64th Consecutive Year of Dividend Increase; Raises Quarterly Dividend by 3.1%
From Johnson & Johnson
Via Business Wire
News headline image
Johnson & Johnson reports Q1 2026 results, raises 2026 outlook
From Johnson & Johnson
Via Business Wire
News headline image
Dow Jones Stocks In Spotlight: JPMorgan, Johnson & Johnson Among This Week's Earnings Reports ↗
Four of the 30 Dow Jones Industrial Average stocks report this week. Here's a look at the companies and what the key figures to watch are. 
Via Benzinga
Topics Stocks
News headline image
Is This Dividend King With a 63-Year Dividend Streak A Buy Before April 14?
This Dividend King offers a rare mix of safety and upside heading into earnings. 
Via Barchart.com
News headline image
Which Dividend Pharma Stock Should a Value Investor Choose Today? ↗
Bristol Myers Squibb looks like a value buy, so long as its pipeline remains strong. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Nvidia Built an AI Chip Empire. But It's This Other Creation That Makes the Stock a Screaming Buy Today. ↗
The future looks bright for this AI star. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
History Says the Best Time to Buy Stocks May Be Imminent ↗
The best time to buy stocks may be closer than you think -- and history has the receipts. 
Via The Motley Fool
Topics Government Stocks World Trade
News headline image
Better Buy Right Now: Johnson & Johnson Vs. Pfizer ↗
The choice is based on more than just the dividend payout. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Smooth Investing When the Ride Is Bumpy ↗
Diversification is a winning strategy for the long term, especially in a volatile market. 
Via The Motley Fool
News headline image
The $100 Billion Pivot: Why Johnson & Johnson Is My Top Dividend King to Buy in 2026 ↗
This stock might help you sleep more easily at night. 
Via The Motley Fool
Topics Economy Intellectual Property Lawsuit
News headline image
4 Stocks That Can Fund Decades of Passive Income -- Buy Them While They're Down ↗
These defensive consumer stocks are flashing buy signals while the market chases AI hype. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Stocks Rallied After President Donald Trump's Ceasefire in Iran. Here's How to Invest Now. ↗
Moves made now could position your portfolio for success over time. 
Via The Motley Fool
Topics Government Stocks
News headline image
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
From Johnson & Johnson
Via Business Wire
News headline image
Could Buying This Dividend Pharma Stock Today Set You Up for Life? ↗
This Dividend King drug maker's dividend yield is roughly twice that of the S&P 500 index. 
Via The Motley Fool
Topics Stocks
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
Via Investor Brand Network
Topics Artificial Intelligence
News headline image
The Teleflex Pivot: Inside the $1 Billion Share Buyback and Strategic Breakup
Disclaimer: This content is intended for informational purposes only and is not financial advice. Today’s date is April 9, 2026. Introduction In the high-stakes arena of medical technology, few stories... 
Via Finterra
Topics Economy World Trade
News headline image
ImmunityBio (IBRX): From R&D Speculation to Record Commercial Revenue
Today's Date: April 9, 2026 Introduction In the high-stakes arena of biotechnology, few companies have undergone a transformation as dramatic as ImmunityBio, Inc. (NASDAQ: IBRX). Long viewed by Wall... 
Via Finterra
Topics Economy World Trade
News headline image
Robotics and AI in Drug Manufacturing: May Unlock Efficiency Gains, Long-Term Value
From AINewsWire
Via GlobeNewswire
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.